Right now, 2 million people in the United Kingdom are living with or beyond a cancer diagnosis. With this figure set to rise in the future, this study looks at the potential implications and complications for survivors. Every year our board of trustees allocates how much money will go towards funding research. The new research …
Putting Yorkshire at the forefront of cancer research
Saving more children and their families from the devastating consequences of cancer depends on continuous research.
When Candlelighters was formed in 1971, sadly very few of the children survived, but today things are different. Research and medicine has advanced so much over the years that now more than 70 per cent of children go on to lead normal, healthy lives.
In addition to our Candlelighters Children's Cancer Research Laboratory in Leeds, we also help fund external research projects across Yorkshire.
The Candlelighters Children's Cancer Research Laboratory opened in 1992, as a result of a huge fundraising campaign. Led by Professor Sue Burchill, the laboratory now enjoys an international reputation, particularly for research into Ewings Sarcoma. It also attracts funding from other research bodies.
In among the research we've helped fund are:
- Fertility research projects
- Brain tumour research projects
- Research into symptom prevalence and profiles in childhood cancer and leukaemia
- Development of the Yorkshire Specialist Register of cancer and leukaemia in children and young adults.
- Acute Lymphoblastic Leukaemia projects
Below we will post details of specific research projects Candlelighters have supported so far.
Combined with the National Institute for Health Research (NIHR), Cancer Research UK and Leeds Teaching Hospitals NHS Trust, Candlelighters funded research with the purpose of influencing NHS policies and clinical care in paediatric and adolescent medicine.
Over the last 30 years we have been instrumental in the development of the paediatric oncology/haematology research infrastructure in Leeds. Together with other major institutions, Candlelighters is giving talented clinicians the opportunity to learn from world-leading research teams. Ensuring that Leeds continues to lead the way in cancer research.
In 2014 Candlelighters funded Sue Burchill to continue a specific area of research. This work is the result of a decade of dedication and is likely to be used as a tool to stratify patients treatment within the next Neuroblastoma clinical trial.